This document outlines an exclusive GP-led secondary deal for Project Klein, expected to close in June 2018. It involves a mid-market buyout strategy focusing on Europe/UK, with investments in business services and healthcare services. The transaction includes four companies, with key investments in a UK premium distributor and a network of UK medical and cosmetics clinics. The document highlights the investment rationale and Glendower Capital's approach to the transaction.
doj/DataSet10/EFTA01390302.pdf
{"title":"SOF IV — Project Klein","key_people":["Glendower Team"],"document_date":"June 2018","document_type":"tabular","key_locations":["Europe","UK"],"document_subtype":"investment summary","key_organizations":["Glendower Capital"],"reference_numbers":["DB-SDNY-0094764","SDNY_GM_00240948","EFTA01390302"]}